Skip to main content
Equibles

ROYAL BANK OF CANADA

Bank

Position in VRCA — Verrica Pharmaceuticals Inc.

CIK 1000275 TORONTO, A6
Back to VRCA Full portfolio

Position in VRCA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,675
-$429 QoQ
Shares Held
764
-20.8% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#30
of 43 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VRCA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ROYAL BANK OF CANADA holds $2,118,794,122 across 427 Biotechnology names. VRCA ranks #325 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IONS
Ionis Pharmaceuticals Inc
 6,182,479 $490,208,754
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 980,259 $486,924,048
3 ALNY
Alnylam Pharmaceuticals, Inc.
 875,859 $263,659,830
4 INCY
Incyte Corp
 1,132,050 $128,329,182
5 REGN
Regeneron Pharmaceuticals, Inc.
 174,515 $108,817,078
6 MRNA
Moderna, Inc.
 944,457 $66,140,319
7 INSM
INSMED Inc
 416,487 $44,405,840
8 HALO
Halozyme Therapeutics, Inc.
 545,761 $42,716,712

All Filings in VRCA

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,675 764
2026-03-31 $5,104 965
2025-12-31 $3,456 416
2025-09-30 $5,210 1,209
2025-06-30 $2,677 5,053
2025-03-31 $2,833 6,413
2024-12-31 $2,410 3,444
2024-09-30 $37,387 25,785
2024-06-30 $20,338 2,790
2024-03-31 $14,686 2,481
2023-12-31 $64,137 8,762
2023-09-30 $37,062 9,540
2023-06-30 $56,030 9,711
2023-03-31 $27,540 4,237
2022-12-31 $7,829 2,847
2022-09-30 $8,295 2,841
2022-06-30 $581,454 302,841
2022-03-31 $25,919 3,196
2021-12-31 $49,361 5,389
2021-09-30 $33,962 2,717
2021-06-30 $22,215 1,966
2021-03-31 $31,526 2,081
2020-12-31 $16,113 1,400
2020-09-30 $8,382 1,083
2020-06-30 $12,155 1,104
2020-03-31 $16,055 1,469